Electrocardiogram (ECG) Devices Market Size Share Trends Forecast 2026

 

Electrocardiogram (ECG) resting system, ECG Holter monitoring system, ECG stress testing system, and cardiopulmonary stress testing system are some of the widely used ECG systems. Resting ECG device detects arrhythmias while the patient is in resting position. These devices are widely used in hospitals and cardiology clinics. Holter ECG monitoring device is portable and is used for continuous monitoring of heart activities. It can be used to detect occasional cardiac arrhythmias.

Statistics:

The global Electrocardiogram (ECG) Devices Market is estimated to account for US$ 5,589.3 Mn in terms of value by the end of 2027.

Global Electrocardiogram (ECG) Devices Market: Drivers

Low cost of ECG services is expected to propel growth of the global Electrocardiogram (ECG) Devices market over the forecast period. For instance, the cost of an electrocardiogram ranges from US$ 76 to US$ 240.

Global Electrocardiogram (ECG) Devices Market: Opportunities

Use of non-conventional energy sources in Electrocardiogram (ECG) Devices is expected to offer lucrative growth opportunities for players in the market. For instance, in May 2019, researchers from Pukyong National University, South Korea, reported designing an ECG device that is powered by solar energy with an output voltage of 2.4 V and a power out of 0.25 W.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/2657

Global Electrocardiogram (ECG) Devices Market: Restraints

Inaccuracy of wearable Electrocardiogram (ECG) Devices is expected to hinder growth of the global Electrocardiogram (ECG) Devices market. Electrocardiogram (ECG) Devices often offer false diagnostics of heart conditions. For instance, according to a research published in April 2019 by the Harvard Medical School, 30% of wearable devices yield inaccurate results.

Key Takeaways:

The ECG Resting System segment in the global Electrocardiogram (ECG) Devices market was valued at US$ 2,226.2 Mn in 2019 and is expected to reach US$ 3,089.4 Mn by 2027 at a CAGR of 4.2% during the forecast period. Increasing adoption of expansion strategies from major players operating in the market to enhance their product portfolio and expand geographical footprint is anticipated to drive the growth of the segment during the forecast period.

The hospital segment held dominant position in the global Electrocardiogram (ECG) Devices market in 2014, accounting for 54.6% share in terms of value during the forecast period. Increasing prevalence of cardiovascular diseases (CVDs) is expected to boost growth of the segment during the forecast period.

Market Trends

Minor ST depression in the ECG is associated with cardiovascular disease and increased mortality. For instance, according to a study published in the Journal of Electrocardiology in December 2019, lower ST levels in ECG lateral leads are linked with all-cause mortality.

Browse Research Report: https://www.coherentmarketinsights.com/market-insight/electrocardiogram-ecg-devices-market-2657

Artificial Intelligence (AI) can be used for automatic detection of hypoglycaemia using ECG. For instance, in January 2020, researchers at University of Warwick, U.K., reported the use of personalized medicine approach and AI to automatically detect nocturnal hypoglycemia using a few heartbeats of raw ECG signal recorded with non-invasive, wearable devices.

Regulations

Regulations for wireless devices:

In the U.S., wireless medical devices are regulated by Food and Drug Administration (FDA), Federal Communications Commission (FCC), and Centers for Medicare and Medicaid Services (CMS)

Global Electrocardiogram (ECG) Devices Market: Competitive Landscape

Major players operating in the global Electrocardiogram (ECG) Devices market include,  Cardiac Insight Inc., Koninklijke Philips N.V., General Electric Company, CardioNet Inc., Mindray Medical International Limited, Spacelabs Healthcare (a subsidiary of OSI Systems Inc.), Schiller AG, Compumed Inc., Nihon Cohden Corporation, and Welch Allyn Inc..

Global Electrocardiogram (ECG) Devices Market: Key Developments

March 2019: VivaLNK, a connected healthcare solutions provider, launched its IoT-enabled medical wearable Sensor Platform that enables internet of health things (IoHT) solution partners to easily capture streams of patient data such as temperature and ECG rhythms

July 2018: LifeSignals Group Inc. received the U.S. FDA clearance for its wireless LP1100 Life Signal Patch, a wearable ECG patch

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/2657

About Coherent Market Insights:            

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

mailto:sales@coherentmarketinsights.com

U.S. Office:

Name:  Mr. Shah

Coherent Market Insights 1001 4th Ave,

# 3200 Seattle, WA 98154, U.S.

US :  +1-206-701-6702

UK :  +44-020-8133-4027

JAPAN :  +050-5539-1737

Hodgkin’s Lymphoma Treatment Market Size, Shares, Insights Forecast 2018-2026

 

Global Hodgkin’s Lymphoma Treatment Market Regional Analysis

North America is expected to hold a dominant position in the global Hodgkin’s Lymphoma Market over the forecast period. Frequent research and development activities done by the government and other organizations is expected to drive the North America Hodgkin’s lymphoma treatment market growth. For instance, in December 2016, Ohio State University Comprehensive Cancer Center and National Cancer Institute (NCI) commenced a U.S. FDA clinical trial of Ibrutinib in combination with Nivolumab, in the patients suffering from classical Hodgkin’s Lymphoma, in the U.S to study its efficacy. Ibritunib may block the cancer cell growth by blocking the enzymes responsible for growth and Nivolumab may block cancer cells by targeting different cells. Currently, it’s in the second phase of clinical trials. The study involves 17 participants and is estimated to be completed by 2020.

Furthermore, various outside organizations are involved in research and development activities for development and gaining the U.S. FDA approval of novel Hodgkin’s lymphoma treatment drug in the U.S.

Lymphoma is a cancer caused in lymphocytes of the body, i.e. white blood cells. It is of two types – Hodgkin’s Lymphoma and Non-Hodgkin’s Lymphoma. Hodgkin’s Lymphoma can be characterized into two categories – classic and nodular lymphocyte predominant. Some of the signs indicating presence of Hodgkin’s Lymphoma in the body is fever, sudden weight loss, and swollen lymph nodes. Hodgkin’s Lymphoma is mostly treated with chemotherapy alone or with the combination of radiotherapy.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/2658

Global Hodgkin’s Lymphoma Treatment Market Drivers

Approvals of the drugs by regulatory bodies for the treatment of Hodgkin’s lymphoma is expected to drive the global Hodgkin’s lymphoma market growth. In 2018, Seattle Genetics, Inc. received the Health Canada approval for its supplemental New Drug Submission that expands the use of Adcetris (brentuximab vedotin) in combination with AVD (Adriamycin, vinblastine and dacarbazine) chemotherapy in patients with previously untreated Stage IV Hodgkin lymphoma (HL). Adcetris is indicated for the treatment of adult patients with previously untreated Stage III or IV classical Hodgkin lymphoma (cHL), in combination with doxorubicin, vinblastine, and dacarbazine.

Furthermore, key players are constantly trying to expand the indications of their already approved drug. For instance, in March 2017, Merck & Co. Inc. received an approval by U.S. Food & Drug Administration (FDA) of the drug, Keytruda for the treatment of classical Hodgkin’s lymphoma. It is approved on the basis of response durability and tumor response rate and is supposed to be administered intravenously into patients. It was originally approved in 2014. Such frequent approvals of drugs by regulatory bodies are expected to impact positively on the global Hodgkin’s lymphoma treatment market growth.

For instance, in September 2017, Chinese PLA General Hospital, a Chinese government organization, commenced its clinical trial of Decitabine in combination with SHR – 1210. It is being used for the treatment of Hodgkin’s lymphoma. SHR – 1210 is a monoclonal antibody, while Decitabine is an investigational drug, which is capable of boosting antigen expression. The clinical study is for analyzing the safety and efficacy of the drugs. Currently, it is in the second phase of clinical trials.

Browse Research Report: https://www.coherentmarketinsights.com/ongoing-insight/hodgkins-lymphoma-treatment-market-2658

Global Hodgkin’s Lymphoma Treatment Market Restraints

Side effects related with drugs used for the treatment of Hodgkin’s lymphoma is expected to adversely affect adoption of these drugs, thereby hindering the global Hodgkin’s lymphoma treatment market growth. For instance, according to American Cancer Society, drugs used for treating Hodgkin’s lymphoma such as doxorubicin and bleomycin can damage heart and lungs respectively. Hence, such side effects of drugs can hinder the global Hodgkin’s lymphoma treatment market growth.

Global Hodgkin’s Lymphoma Treatment Market Key Players

Some of the major players operating in the global Hodgkin’s lymphoma treatment market include Emcure Pharmaceuticals Pvt. Ltd., Aspen Global Inc., Pfizer Inc., Ono Pharmaceuticals Co. Ltd., Corden Pharma Latina SPA, Horizon Pharma USA Inc., Cipla Ltd., Lediant Biosciences Inc., Jansenn Research and Development LLC, and Merck & Co., Inc.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/2658

About Coherent Market Insights:            

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

mailto:sales@coherentmarketinsights.com

U.S. Office:

Name:  Mr. Shah

Coherent Market Insights 1001 4th Ave,

# 3200 Seattle, WA 98154, U.S.

US :  +1-206-701-6702

UK :  +44-020-8133-4027

JAPAN :  +050-5539-1737

Genomics Market Size, Share, Outlook, and Opportunity Analysis, 2019– 2027

 

Genomics Market by Product Type (Consumables, Software, and Others), by Technology (PCR, Microarray, Next Gene Sequencing, Nucleic Acid Extraction and Purification, and Others), by Application (Diagnostics, Drug Discovery and Development, Precision Medicine, Agriculture & Animal Research, and Others), by End Users (Academic and Research Institute, Pharmaceutical & Biotechnology Companies, Hospital and Clinics, and Others), and by Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2019 – 2026

Genomics is the study of human genes and chromosomes. It focuses on structure, function, evolution, mapping, and editing of genomes. Genome is the genetic material of organism, which includes the Deoxyribonucleic acid (DNA). DNA consists the information needed to build the whole human body. Human genome consists of 23 pairs of chromosomes and 24000 genes. This study is divided into various types such as structural genomics, functional genomics, and comparative genomics.

Global Genomics Market Drivers

Increasing new product launches is expected to drive the global genomics market growth. For instance, in January 2019, Contextual Genomics launched two molecular hotspot assays (Liquid Biopsy Test and updated Solid Tumor Panel) for the detection of genomic mutations in blood and solid tumors.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/2660

Furthermore, in May 2015, Rosetta Genomics Ltd. launched OncoGxOne. It is Next Generation Sequencing (NGS) test that profiles tumors for targeted therapy selection and chemotherapeutic tolerance.

Moreover, in September 2018, Zenome launched the first decentralized genomic internet software, which is expected to increase possibilities of safe storage of large amount of genetic data. The main advantage of decentralized genomic internet software is that the degree of security is much higher.

Global Genomics Market Restraints

Lack of qualified and trained professionals in genomics study is a major challenge for the global genomics market growth. For instance, in January 2019, according to express healthcare report, genomics study needs highly qualified and trained professionals to optimize lab workflows and run it efficiently.

Global Genomics Market Regional Analysis

Europe is expected to gain significant share in the global genomics market over the forecast period, owing to increasing launches of new products by key players. For instance, in April 2017, Illumina, Inc. announced launch of its new product VeriSeq NIPT Solution, it is a CE-IVD marked next-generation sequencing (NGS)-based approach to non-invasive prenatal testing (NIPT).

Browse Research Report: https://www.coherentmarketinsights.com/ongoing-insight/genomics-market-2660

This approach includes the CE-IVD marked library preparation and analysis software. This software enables fast, highly accurate, cost-effective, and non-invasive parenteral testing (NIPT).

Furthermore, Asia Pacific is also projected to witness significant growth in the global genomics market during the forecast period, owing to increasing collaboration activities by key players. For instance, in January 2018, 10X Genomics, Inc. collaborated with the Berry Genomics Co. Ltd. Under this collaboration, 10x Genomics, Inc. focuses on development of approaches for next generation non-invasive prenatal testing (NIPT) and developing and offering new services for Berry Genomics Co. Ltd.

Key players operating in the global genomics market include Thermo Fisher Scientific, Inc., Agilent Technologies, Bio-Rad Laboratories, Inc., Illumina, Inc., Pacific Biosciences, Oxford Nanopore Technologies., 23andMe, Inc., Foundation Medicine, Inc. Hoffmann-La Roche Ltd., and Myriad Genetics, Inc.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/2660

About Coherent Market Insights:            

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

mailto:sales@coherentmarketinsights.com

U.S. Office:

Name:  Mr. Shah

Coherent Market Insights 1001 4th Ave,

# 3200 Seattle, WA 98154, U.S.

US :  +1-206-701-6702

UK :  +44-020-8133-4027

JAPAN :  +050-5539-1737

Infertility Drugs Market To Surpass US$ 6.2 Billion By 2026 - Coherent Market Insights

 

Global Infertility Drugs Market, By Drug Type (Clomiphene citrate, Sex hormones, Gonadotropins, Bromocriptine, Cabergoline, Imipramine, Letrozole, and Metformin), By Route of Administration (Oral, Intravenous, Subcutaneous, and Intramuscular), By Gender (Male and Female), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 3.8 billion in 2017, and is projected to exhibit a CAGR of 5.8% over the forecast period (2019 - 2026).

The infertility drugs market size is expanding, owing to increasing research studies for development of breakthrough drugs for the treatment of infertility. According to a research conducted in Princeton University in 2018, researchers have identified a key protein in old, poor-quality Caenorhabditis elegans (microscopic worm) eggs, which controls the aging of gametes. Researchers successfully blocked this protein during the fertile period of the worm (equivalent to woman’s fertility in thirties), and extended egg viability beyond the normal span. If these protein could be removed from human genes, that could represent a 3 to 6 year extension of female fertility. Increasing awareness about reproductive health in the population is also highly contributing to the infertility drugs market growth. For instance, RESOLVE - The National Infertility Association organizes National Infertility Awareness Week (NIAW) every year in the last week of April since 2010.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/2665

The goal of the week is to raise awareness about infertility in maximum population, to encourage advocacy for insurance in infertility drugs, and help couples with infertility cope with their disease. Browse 17 Market Data Tables and 12 Figures spread through 145 Pages and in-depth TOC on " Global Infertility Drugs Market, By Drug Type (Clomiphene citrate, Sex hormones, Gonadotropins, Bromocriptine, Cabergoline, Imipramine, Letrozole, and Metformin), By Route of Administration (Oral, Intravenous, Subcutaneous, and Intramuscular), By Gender (Male and Female), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies) and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Forecast to 2026"

Furthermore, various organizations are focused on launching new programs to help infertile couples. For instance, in 2014, EMD Serono a subsidiary of Merck KGaA, Germany launched its Compassionate Corps Program, a patient assistance program to provide fertility medications for eligible U.S. veterans who were infertile due to a service-related injury. The company provides selected IVF stimulation medications at no charge for up to two IVF cycles per year. Moreover, Merck KGaA partnered with Genea Biomedx in May 2015, securing global rights to Genea's portfolio of fertility products.

Browse Research Report: https://www.coherentmarketinsights.com/market-insight/infertility-drugs-market-2665

Key Takeaways of the Infertility Drugs Market:

The global infertility drugs market is expected to expand at a CAGR of 5.8% during the forecast period (2019–2026), owing to increasing research & development and new infertility drug launches by companies.

Among the drug type, the Clomiphene citrate segment is expected to hold major revenue share in 2026, as it is the most effective drug to treat infertility. According to a study published in National Centre for Biotechnology Information (NCBI) in 2012, a comparative study on effectiveness of clomiphene citrate and tamoxifen in ovulation induction in infertile women showed that women treated with Clomiphene citrate showed 64% increase in pregnancy rate than the women treated with tamoxifen, which showed only 40% increase in pregnancy rate.

Major players operating in the global infertility drugs market include Merck & Co., Ferring Pharmaceuticals, LIVZON Pharmaceutical Group Inc., AbbottLaboratories, Bayer AG, and Zydus Pharmaceuticals.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/2665

About Coherent Market Insights:            

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

mailto:sales@coherentmarketinsights.com

U.S. Office:

Name:  Mr. Shah

Coherent Market Insights 1001 4th Ave,

# 3200 Seattle, WA 98154, U.S.

US :  +1-206-701-6702

UK :  +44-020-8133-4027

JAPAN :  +050-5539-1737

Veterinary Radiography Flat Panel Detector Market Opportunity Analysis-2027

 

Global Veterinary Radiography Flat Panel Detector Market Regional Analysis

North America is expected to hold a dominant position in the global Veterinary Radiography Flat Panel Detector Market over the forecast period. Factor such as presence of qualified veterinary technicians is expected to have a positive impact on the North America veterinary radiography flat panel detector market growth. For instance, in September 2018, National Association of Veterinary Technicians in America established the Academy of Veterinary Technicians in Diagnostic Imaging. It focuses on training veterinary technicians in terms of emerging technologies such as computed tomography (CT), ultrasonography, radiography (which includes flat panel detectors), and Magnetic Resonance Imaging (MRI). Increase in qualified veterinary personnel for handling technologies such as detectors, is expected to support global veterinary radiography flat panel detector market growth.

Digital radiography is a part of diagnostic imaging method which is used for examining any injury or disease in animals. Any part of the body such as bones, heart, lungs, and abdomen can be examined with the help of digital radiography. Flat panel detectors are part of digital radiography. Flat panel detectors convert X-Rays into light or charge, which is then read with the help of thin film transistors. There are two types of flat panel detectors which are indirect conversion and direct conversion detectors.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/2671

Global Veterinary Radiography Flat Panel Detector Market Drivers            

Adoption of strategies such as partnerships, collaborations, mergers and acquisitions by key players is expected to positively influence the global veterinary radiography flat panel detector market growth. For instance, in April 2019, Varex Imaging Corporation, a medical X–ray imaging component manufacturing company, acquired Direct Conversion AB (publ), a company focused on developing and manufacturing X-ray based imaging solutions, in order to expand their product portfolio. Varex Imaging Corporation is going to include linear array digital detectors to its product line (manufactured by Direct Conversion AB) through this acquisition. Also, in May 2017, Varex Imaging Corporation acquired the medical imaging business of PerkinElmer Inc. These factors are expected to drive global veterinary radiography flat panel detector market growth.

Furthermore, strategies such as expansion of business in other regions by key players is also expected to propel the global veterinary radiography flat panel detector market growth over the forecast period. For instance, in February 2019, Varex Imaging Corporation, U.S. based company showcased products such as an X-ray tube, flat panel detectors, and software solutions, at the European Congress of Radiology conference. The company showcased its latest products alongside other radiology professionals, radiologists, and physicists at the conference.

Browse Research Report: https://www.coherentmarketinsights.com/ongoing-insight/veterinary-radiography-flat-panel-detector-market-2671

Global Veterinary Radiography Flat Panel Detector Market Restraints

There are few side effects associated with radiography such as anemia, vomiting, internal bleeding, diarrhea, and permanent sterilization. Moreover, alternatives to radiography such as ultrasonic testing can lead to a decrease in adoption of radiography flat panel detectors. Hence, these factors are expected to restrain the global veterinary radiography flat panel detector market growth.

Global Veterinary Radiography Flat Panel Detector Market Key Players

Some of the major players operating in the global veterinary radiography flat panel detector market include, PROTEC GmbH & Co. KG, PLH Medical Ltd., OR Technology, Raytech Diagnostics, Varex Imaging Corporation, FUJIFILM Corporation, Diagnostic Imaging Systems, Vieworks Co., Ltd., and MyVet.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/2671

About Coherent Market Insights:            

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

mailto:sales@coherentmarketinsights.com

U.S. Office:

Name:  Mr. Shah

Coherent Market Insights 1001 4th Ave,

# 3200 Seattle, WA 98154, U.S.

US :  +1-206-701-6702

UK :  +44-020-8133-4027

JAPAN :  +050-5539-1737

Molecular Quality Control Market Size, Trends, Shares, Forecast – 2018-2026

 

Molecular Quality Control Market by Product Type (Independent Control, Instrument Specific Control (DNA Sequencing and NGS, PCR, and Others)), by Analyte (Single Analyte, and Multi Analyte), by Application (Oncology, Genetic Testing, Infectious Diseases, and Others), by End Users (Clinical Laboratories, Hospitals and Clinics, Research and Academic Institutes, and Others), and by Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 – 2026

Molecular quality control mainly used for monitoring the performance of in vitro nucleic acid testing procedures for viral load assays, healthcare-associated infections (HAIs) including bloodstream infections, urinary tract infections, pneumonia, and other infections related to sexually transmitted diseases. Main focus of molecular quality control is to test molecular diagnostic products, identify defects and report them to management authorities.

Molecular Quality Control Market Drivers

Expansion of business by key players is expected to boost the molecular quality control market growth. For instance, in July 2016, Bio-Rad Laboratories, Inc. announced its expansion into the molecular diagnostic testing market with the launch of its new quality control system Amplichek Quality Control. This quality control is used for molecular diagnostic testing of infectious diseases.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/2674

Furthermore, in April 2019, Bruker announced the expansion for its MALDI Biotyper, IR Biotyper and Fluorocycler XT product lines. These products will be used for microbial identification, infection control, and molecular diagnostics of infectious diseases.

Moreover, increasing partnership activities are expected to drive the molecular quality control market growth. For instance, in February 2018, Randox Laboratories announced its strategic partnership with Qnostics to enhance the market potential of its Qnostics products.

Molecular Quality Control Market Restraints

Inaccurate genetic tests are expected to hinder growth of the molecular quality control market. For instance, in August 2017, Invitae Corporation identified a quality control issue with a hereditary cancer test, which provided false, negative results. This hereditary cancer test is carried out on those patient who have a rare genetic variant in the MSH2 gene which is associated with the Lynch syndrome.

Molecular Quality Control Market Regional Analysis

On the basis of region, the global molecular quality control market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

Browse Research Report: https://www.coherentmarketinsights.com/ongoing-insight/molecular-quality-control-market-2674

North America is expected to hold a dominant position in the global molecular quality control market, owing to increasing launches of new control panels by key players. For instance, in December 2018, Microbiologics, Inc. launched two new panels, Group A Streptococcus (GAS) and respiratory molecular assays, for quality control processes. These two panels include convenient features such as multiplexed pellets, swabs that mimic patient sample processing, and room temperature storage.

Furthermore, Asia Pacific is also projected to witness significant growth in the global molecular quality control market, owing to increasing partnership activities by key players. In June 2016, Thermo Fisher Scientific Inc., announced its partnership with West China Hospital of Sichuan University to enhance quality of pathological research and diagnosis and to accelerate development of precise pathological diagnosis.

Key players operating in the, global molecular quality control market include Seracare Life Sciences, Inc., Zeptometrix, Thermo Fisher Scientific, Abbott Laboratories, Maine Molecular Quality Controls, Inc., Quidel, Qnostics, Bio-Rad Laboratories, Roche Diagnostics, Microbiologics, Inc., and Theranostica.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/2674

About Coherent Market Insights:            

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

mailto:sales@coherentmarketinsights.com

U.S. Office:

Name:  Mr. Shah

Coherent Market Insights 1001 4th Ave,

# 3200 Seattle, WA 98154, U.S.

US :  +1-206-701-6702

UK :  +44-020-8133-4027

JAPAN :  +050-5539-1737

Physiotherapy Equipment Market Size, Share, Outlook, Analysis, 2019– 2027

 

Physiotherapy equipment help professionals effectively treat their patients and also help those with injuries and physically inhibiting conditions and provide at-home physical therapy treatment.

Statistics:

The global Physiotherapy Equipment Market is estimated to account for US$ 20,706.3 Mn in terms of value in 2020 and is expected to reach US$ 33,034.3 Mn by the end of 2027.

Global Physiotherapy Equipment Market: Drivers

Increasing prevalence of neurological diseases is expected to propel growth of the global physiotherapy equipment market over the forecast period. For instance, according to the data from Alzheimer's Association, around 5.7 million people in the U.S. were suffering from Alzheimer’s disease in 2018.

Global Physiotherapy Equipment Market: Restraints

Lack of health insurance in developing countries such as China and India is expected to hinder growth of the global physiotherapy equipment.

Key Takeaways:

The global physiotherapy equipment market was valued at US$ 19,387.9 Mn in 2019 and is forecast to reach a value of US$ 33,034.3 Mn by 2027 at a CAGR of 6.9% between 2020 and 2027. Major factor driving the growth of global physiotherapy equipment market during the forecast period include technological advancement, and increasing prevalence of cardiovascular diseases.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/2688

Equipment held dominant position in the global physiotherapy equipment market in 2019, accounting for 65.6% share in terms of value, followed by Accessories, respectively. Launches of new physiotherapy equipments is expected to support growth of the market over the forecast period.

Market Trends

High incidence of sport injuries is expected to propel growth of the global physiotherapy equipment market over the forecast period. For instance, according to the National High School Sports-Related Injury Surveillance Study 2017-2018, 1,367,490 cases of sport-related were recorded in high schools in the U.S.

Moreover, rising awareness about therapeutic applications of physical therapy is also expected to aid in growth of the market. World Physical Therapy Day is a key campaign led by the by the World Confederation for Physical Therapy (WCPT). September 8 is celebrated as World Physical Therapy Day. It is a day when various awareness campaigns are launched about PTs and their role in maintaining health of patients.

Global Physiotherapy Equipment Market: Competitive Landscape  

Major players operating in the global physiotherapy equipment market include, Enraf-Nonius B.V., DJO Global, EMS Physio Ltd., Dynatronics Corporation, A. Algeo Limited, BTL Industries, Inc., HMS Medical Systems, Whitehall Manufacturing, Patterson Companies, Inc., and Isokinetics, Inc.

Browse Research Report: https://www.coherentmarketinsights.com/market-insight/physiotherapy-equipment-market-2688

Global Physiotherapy Equipment Market: Key Developments

Major players operating in the global physiotherapy equipment market are focused on offering standard products to enhance their market share. For instance, in November 2018, Algeos renewed its ISO 9001:2015 and ISO 13485:2016 ISO Quality Standards.

Major players operating in the global physiotherapy equipment market are also focused on adopting various strategies to enhance their market share. For instance, in February 2018, Dynatronics Corporation announced that PROTEAMTM by Hausmann has renewed its Platinum Partnership with PFATS (Professional Football Athletic Trainers Society), an organization made up of the Athletic Trainers employed by the teams of the National Football League.

Similarly, in January 2019, BTL Industries, Inc. attended Arab Health 2019 held in Dubai World Trade Centre in Dubai, United Arab Emirates.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/2688

About Coherent Market Insights:            

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

mailto:sales@coherentmarketinsights.com

U.S. Office:

Name:  Mr. Shah

Coherent Market Insights 1001 4th Ave,

# 3200 Seattle, WA 98154, U.S.

US :  +1-206-701-6702

UK :  +44-020-8133-4027

JAPAN :  +050-5539-1737

Neurocognitive Disorder Treatment Market Forecast Opportunity Analysis-2027

 

Global Neurocognitive Disorder Treatment Market: Market Dynamics

Increasing prevalence of neurocognitive disorder is expected to augment the global Neurocognitive Disorder Treatment Market growth. Due to advancement in technology and inventions such as Al and adoption of unhealthy work practices, increased cardiovascular issues are boosting the global neurocognitive disorder market. Moreover, increased addiction of drugs and alcohol in youth and also changing climate conditions or respiratory diseases are causing neurocognitive disorders and driving the market growth. Furthermore, increase in number of geriatric population is also the factor affecting the market growth. Approvals of the drugs associated with the treatment from the regulatory bodies is the factor that drives the market growth. For instance, on April 11, 2019, the U.S.FDA accepted the resubmitted new drug application (NDA) for instradefylline (KW-6002), which is an oral selective adenosine receptor antagonist for use as adjunctive treatment for Parkinson’s disease in adults. On May 20, 2019, the U.S.FDA approved Neuronascent Investigational New Drug (IND) application for NNI-362.

The clinical trials of some drugs are terminated, as they are not able to reach to their primary endpoint. For instance, on March 21, 2019, Biogen and Eisei, Co., Ltd announced the decision to discontinue the global phase 3 trial of Aducanumab, which is designed to evaluate the safety and efficacy of an antibody-aducanumab in patients with Alzheimer disease. This decision to stop the trial is based on the analysis that trials were unlikely to improve the people’s memory and thinking sufficiently by the end of the trial. This discontinuation of trials is the major restraining factor for the market.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/2676

Neurocognitive disorders include dementia, delirium, and mild cognitive impairment, which is characterized by decline of the level of cognitive functioning. Neurocognitive deficit is a reduction or impairment of cognitive functions and affects nerve cells and often impact the person’s ability to remember, to reason, and to make judgments. The neurocognitive disorders have different clinical characteristics with Alzheimer disease, front temporal degeneration, cerebrovascular disease, traumatic brain injury, Lewy body disease, and infections showing the common causes. Alzheimer disease is the most common cause of neurocognitive disorder. In the early stages of Alzheimer, people are not able to remember the recent events, conversations, and names of people and may also experience the depression. Individuals with neurocognitive disorder show the side effects like mood disturbances including apathy, depression, anxiety and sleep disturbance including insomnia, hypersomnia.

Neurocognitive disorder treatments include pain medications, surgeries, physical therapy, bed rest, and others. Furthermore, for treatment of neurocognitive disorder, antibiotics are used to clear the remaining infections, which is affecting the brain, such as meningitis.

Global Neurocognitive Disorder Treatment Market: Regional Dynamics

North America is expected to hold a dominant position in the global neurocognitive disorder treatment market, owing to adoption of advanced technology and rising number of neurocognitive disorder patients. According to the World Health Organization (WHO), nearly 35.6 million people live with dementia worldwide. The number of geriatric population worldwide and related dementia patients is expected to rise up to 65.7 million in 2030 and 115.4million in 2050. Furthermore, according WHO, the prevalence of dementia is increasing exponentially with age and sex in North America region, doubling in every 5.5 years. Moreover, satisfactory reimbursement policies, rising adoption of advance precautious methods and increasing penetration of life science analytics for monitoring health changes continuously are factors driving the growth of market in North America.

Browse Research Report: https://www.coherentmarketinsights.com/ongoing-insight/neurocognitive-disorder-treatment-market-2676

Global Neurocognitive Disorder Treatment Market: Competitive Landscape

The key players in global neurocognitive disorder treatment market are focusing on developing innovative, new, and efficient neurocognitive disorder treatment drugs that are launched in the market to meet the demand from consumers for various types of neurocognitive disorder treatments. For instance, in March 2018, Biogen announced to enter into an agreement to acquire Pfizer Inc. phase 2b ready AMPA receptor potentiator for cognitive impairment.

Furthermore, in May 2019, T3D therapeutics received grant of US$ 9 million from National Institute on Aging (NIA) to develop drug T3D-959 for neurocognitive disease.

Key players operating in the global neurocognitive disorder treatment market include A B Science, Abbive, A C immune, Biogen, Eisai, Immunobrain, Mediti Pharma Inc., Ono Pharmaceuticals, Proclar Biosciences, Problodrug AG, Roche, T3D Therapeutics, and Purdue Pharma. 

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/2676

About Coherent Market Insights:            

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

mailto:sales@coherentmarketinsights.com

U.S. Office:

Name:  Mr. Shah

Coherent Market Insights 1001 4th Ave,

# 3200 Seattle, WA 98154, U.S.

US :  +1-206-701-6702

UK :  +44-020-8133-4027

JAPAN :  +050-5539-1737

Medical Vacuum System Market To Surpass US$ 1.9 Billion By 2026 - (CMI)

 

The Global Medical Vacuum System Market, by Product Type (Standalone, Centralized, Portable, and Others), by Technology (Dry Claw Vacuum Pump, Oil-Sealed Liquid Ring, Water-Sealed Liquid Ring, Oil-Sealed Rotary vane, and Others), by Application (Diagnostics, Wound Care, Anesthesiology, Gynecology, and Others), by End User (Hospitals and Clinics, Diagnostic Centers, Ambulatory Surgical Hospitals, Academic and Research Institutes, Pharmaceutical and Biotechnological Companies, and Others), by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), was valued at US$ 1,176.4 million in 2018, and is projected to exhibit a CAGR of 6.6%, during the forecast period (2019-2026), as highlighted in a new report published by Coherent Market Insights.

Increasing product launch activities by key players is expected to drive the global medical vacuum system market growth. For instance, in February 2018, BeaconMedaes Lab launched new MSV Rotary Medical Screw Vacuum System. It offers large and efficient vacuum service to medical and laboratory applications. The systems can help to reduce costs associated with multiple vacuum demands mostly in hospital and laboratory setting. Furthermore, expansion of business by key players is expected to drive growth of global medical vacuum system market. For instance, in January 2016, RGS  launched its new subsidiary branch RGS Vacuum Solutions S.r.l. RGS Vacuum Solutions produces industrial vacuum cleaner, powder transfer system, centralized vacuum system, and accessories. Hence, business expansion activities related to manufacturing of vacuum systems will support the global medical vacuum system market growth.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/2673

Browse 37 Market Data Tables and 32 Figures spread through 167 Pages and in-depth TOC on "Medical Vacuum Sysetm Market, by Product Type (Standalone, Centralized, Portable, and Others), by Technology (Dry Claw Vacuum Pump, Oil-Sealed Liquid Ring, Water-Sealed Liquid Ring, Oil-Sealed Rotary vane, and Others), by Application (Diagnostics, Wound Care, Anesthesiology, Gynecology, and Others), by End User (Hospitals and Clinics, Diagnostic Centers, Ambulatory Surgical Hospitals, Academic and Research Institutes, Pharmaceutical and Biotechnological Companies, and Others), by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Forecast to 2026"

Increasing number of merger and acquisition activities by key players is expected to drive the global medical vacuum system market growth. For instance, in July 2015, Nilfisk Group acquired Kerrick, a provider of industrial and commercial cleaning equipment, for distribution of cleaning equipment such as vacuum cleaners. Nilfisk Group is a supplier of cleaning equipment including vacuum cleaner for industrial as well as commercial market. Kerrick is a supplier of industrial vacuum equipment. Furthermore, in March 2018, Atlas Copco acquired Walker Filtration Ltd, manufacturer of equipment for the treatment of compressed air, gas and vacuum.

Under this acquisition, the business of Walker Filtration Ltd, has been operated as a part of the Medical Gas division in Atlas Copco’s Compressor Technique business area. Moreover, increasing number of approval activities by regulatory authorities for medical vacuum system is expected to propel growth of global medical vacuum system market. For instance, in October 2018, ConvaTec Group Plc. received U.S. Food and Drug Administration (FDA) approval for its negative pressure wound therapy system Avelle. Avelle is a small, portable, and disposable vacuum system, which is used for wound healing.

Browse Research Report: https://www.coherentmarketinsights.com/market-insight/medical-vacuum-system-market-2673

Key Takeaways of the Global Medical Vacuum System Market:

The global medical vacuum system market is expected to witness a CAGR of 6.6% during the forecast period (2019–2026), owing to increasing collaboration activities by key players. For instance, in November 2018, Busch LLC collaborated with the Pfeiffer Vacuum Technology AG. Under this collaboration, Busch LLC focuses on developments of various segments such as sales & services, research and development, and improve the vacuum product line.

Among regions, Asia Pacific is expected to witness significant growth in the medical vacuum system market, owing to high presence of key manufacturers and suppliers of medical vacuum systems in the region. For instance, majority of key manufacturers and suppliers of medical vacuum system such as Medical Corporation, Olympus Corporation, RGS Vacuum Solution, Hunan Eter Electronic Medical project Co, Ltd., and Weifang Km Electronics Co, Ltd, belong to Japan, India, and China.

Major players operating in the global medical vacuum system market include, Asahi Kasei ZOLL Medical Corporation, INTEGRA Holdings, Medela AG, Precision Medical, Inc., Dregerwerk, AG & Co KGaA, Allied Healthcare Products Inc. Gardner Denver Holdings, Busch Holdings GmbH, Laerdal Medical, and Air Techniques

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/2673

About Coherent Market Insights:            

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

mailto:sales@coherentmarketinsights.com

U.S. Office:

Name:  Mr. Shah

Coherent Market Insights 1001 4th Ave,

# 3200 Seattle, WA 98154, U.S.

US :  +1-206-701-6702

UK :  +44-020-8133-4027

JAPAN :  +050-5539-1737

Precision Medicine Software Market Size Share Trends Forecast 2026

 

Precision Medicine Software Market by Delivery Type (On Premise and Cloud-Based), by Application (Oncology, Pharmacogenomics, Rare Diseases, and Others), by End Users (Research Centers, Government Institutes, Pharmaceutical and Biotechnological Companies, and Others), and by Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 – 2026

Precision medicine software is an emerging approach for the prevention and treatment of diseases such as cancer, rare illness, and infectious diseases. It is a combination of molecular biology systems and techniques. These techniques are helpful to the clinicians and physicians for efficiently monitoring the patient. Precision medicine software is used for advancements in genetic research and genomics.

Global Precision Medicine Software Market Drivers

New launches of bioinformatics platforms is expected to drive the global precision medicine software market growth. For instance, in January 2019, XIFIN launched its new precision medicine informatics platform (VisualSrata), which is helpful for the healthcare professionals to gain insights, make decisions, and improve patient care and outcome.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/2683

Furthermore, new molecular strategy launches is expected to propel the global precision medicine software market growth. For instance, in April 2018, Harvard’s Wyss Institute launched new molecular strategy (NuProbe). NuProbe is a type of DNA nanotechnology-based variant-detecting method. It is a fast, low-cost, and multiplexed molecular diagnostic tool for the diagnosis of various diseases including cancer and infectious diseases.

Moreover, launches of new genomic tools is expected to support the global precision medicine software market share. For instance, in September 2018, Ariel Precision Medicine, Inc. launched its new genomics tool ArielDx for personalized management and early diagnosis of pancreatic diseases.

Global Precision Medicine Market Software Restraints

Product recall is the major challenge, which is expected to hinder the global precision medicine software market growth. For instance, in January 2018, Phillips Medical System Inc., received product recall letter from U.S Food and Drug Administration (FDA) for its Brilliance Big Core CT. This software is recalled as error has been detected in production of X-ray tubes. That may result in inability to generate Computed Tomography (CT) images.

Global Precision Medicine Software Market Regional Analysis

North America is expected to hold dominant position in the global precision medicine software market, owing to increasing government initiative over the forecast period. For instance, in January 2019, NIH (National Institutes of Health) and Fitbit launched their first digital health technology initiative for the advanced precision medicine study. This initiative is known as All of Us Research Program. It is expected to improve the prevention and treatment of diseases, which are based on individual differences in lifestyle, environment, and genetics.

Browse Research Report: https://www.coherentmarketinsights.com/ongoing-insight/precision-medicine-software-market-2683

Furthermore, increasing new platform launches in the U.S. is expected to propel the global precision medicine software market growth. For instance, in November 2016, American Heart Association (AHA) announced its new launch of cloud-based precision medicine platform in collaboration with Amazon Web Services (AWS). Main aim of this platform is to assist the clinicians and researchers in collection of the data and to accelerate solutions for cardiovascular disease treatments.

Moreover, Asia Pacific is also projected to witness significant growth in the global precision medicine software market, owing to increasing business expansion activities by key players. For instance, in September 2018, Konica Minolta, Inc. announced the launch of its new business in precision medicine Konica Minolta Precision Medicine, Inc. in Japan. They focus on development of technologies, medicine platform, and discovering new therapies.

Key players operating in the precision medicine software market include Syapse, Inc., 2bPrecise LLC, Foundation Medicine, Inc., Fabric Genomics, SOPHiA GENETICS SA, Gene42, Inc., LifeOmic Health, LLC, NantHealth, Inc., and Koninklijke Philips N.V.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/2683

About Coherent Market Insights:            

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

mailto:sales@coherentmarketinsights.com

U.S. Office:

Name:  Mr. Shah

Coherent Market Insights 1001 4th Ave,

# 3200 Seattle, WA 98154, U.S.

US :  +1-206-701-6702

UK :  +44-020-8133-4027

JAPAN :  +050-5539-1737

Drug Delivery Technologies Market Size Share Trends Forecast 2026

 

Drug Delivery Technologies Market - Regional Insights

On the basis of region, the global Drug Delivery Technologies Market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America holds dominant position in the global drug delivery technologies market, owing to the launch and adoption of novel technologies. For instance, in January 2019, Amneal Pharmaceuticals received the U.S. Food and Drug Administration (FDA) approval for its generic Exelon patch used for treatment of Alzheimer disease through the transdermal drug delivery.

Drug delivery system is a method in which the therapeutic substances are delivered through general route of administration to obtain the therapeutic effect in humans or animals. The correct dose of drugs release their functional ingredients in the targeted area at the appropriate time. Drug delivery technologies helps to improve the absorption, distribution, elimination, and drug release profile for developing the product safety and efficiency. Drug delivery technologies are considered an important aspect of pharmaceutical products which are often used by pharmaceutical companies for extending the product’s lifecycle.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/2690

Drug Delivery Technologies Market Drivers

Increasing prevalence of chronic diseases, growing demand for biologics, technological advancements, and new product launches are some of the factors driving the growth of the market. According to the National Center of Biotechnology Information (NCBI), in 2018, around 45%, or 133 million, Americans were affected by one of the chronic diseases.

Moreover, the Capsugel, a global leader in delivering high quality, innovative dosage forms to the healthcare industry, launches the new drug delivery system as per the commitment to innovate for their costumer. For instance, in October 2015, Capsugel announced the global commercial launch of its enTRinsic drug delivery technology, providing full enteric protection and targeted release of gastric acid and heat sensitive active ingredients to the upper gastrointestinal tract.

Furthermore, in April 2019, Aquestive Therapeutics, Inc. announced that the U.S. Food and Drug Administration (FDA) accepted the company’s New Drug Application (NDA) for their investigational product, Riluzole oral film (ROF), which the company intends to market under the brand name, Exservan. ROF is used for treatment of amyotrophic lateral sclerosis (ALS). ROF is delivered through a postage stamp sized film which dissolves in the mouth. The FDA had designated orphan drug status to the drug in January 2018.

Browse Research Report: https://www.coherentmarketinsights.com/ongoing-insight/drug-delivery-technologies-market-2690

However, risk factors such as needle stick injuries and side effects of drugs are restricting the market growth to a certain level. According to a 2014 estimate by the Occupational Safety and Health Administration (OSHA), 5.6 million workers in the healthcare industry are at a risk of needle sticks and sharps related injuries which expose the workers to blood borne pathogens.

Drug Delivery Technologies Market - Competitive Landscape

Key players operating in the global drug delivery technologies market are focused on innovations related to drug delivery technologies, in order to improve patient compliance. For instance, in July 2018, Merck Pharmaceuticals and InnoCore Pharmaceuticals entered into a global collaboration agreement for InnoCore’s proprietary SynBiosys biodegradable polymer platform. The drug delivery technologies are used to develop sustained release solutions for biologicals in injectable formulations. The sustained release solutions play important role in drug formulation because it improve the patient adherence.

Some of the key players operating in the global drug delivery technologies market includes 3M, Bayer AG, Becton, Dickinson & Company, Johnson & Johnson, Pfizer, Inc., Novartis AG, Glaxosmithkline PLC, Vectura Group Plc., Roche Holding AG, Generex Biotechnology, Antares Pharma, Inc., Alkermes, Merck & Co., Inc, and Sanofi, Aradigm Corp.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/2690

About Coherent Market Insights:            

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

mailto:sales@coherentmarketinsights.com

U.S. Office:

Name:  Mr. Shah

Coherent Market Insights 1001 4th Ave,

# 3200 Seattle, WA 98154, U.S.

US :  +1-206-701-6702

UK :  +44-020-8133-4027

JAPAN :  +050-5539-1737